Geoffrey Cho is a Cardiology physician affiliated with Cedars-Sinai Smidt Heart Institute. OpenAlex indexes 27 publications with 311 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Ucla Medical Plaza Ste 630
Los Angeles, CA 900957419
Telephone
310-825-9011Provider last certified this registry record 17 Sept 2020.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cleerly, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
92.3%Adenosine Receptor Agonist40.9%Regadenoson100%Part B, office-administered≥121 patientsBeta blocker15.3%Metoprolol Succinate46%Carvedilol41%Metoprolol Tartrate14%Part D≥41 patients+ 10 more classes in this area
Blood & clotting
6.6%Factor Xa inhibitor4.7%Eliquis75%Xarelto25%Part D<11 patientsP2Y12 inhibitor1.9%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
1.1%SGLT2 inhibitor1.1%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AI-Driven Quantitative Coronary CT Angiography in Suspected Coronary Artery Disease
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
2026 - AI-Driven Quantitative Coronary CT Angiography in Suspected Coronary Artery Disease: Multicenter CONFIRM2 Registry.
Open Access CRIS of the University of Bern
2026 - Prognostic value of aI-based quantitative coronary CTA vs human reader-based visual assessment: results from the CONFIRM2 registry
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Aakriti Gupta, MD, BS
Cedars-Sinai Smidt Heart Institute
Joshua Goldhaber, MD
Cedars-Sinai Smidt Heart Institute
Janet Wei, MD
Cedars-Sinai Smidt Heart Institute
Eugenio Cingolani, MD
Cedars-Sinai Smidt Heart Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”